About 10% of hypothyroid patients have reduced quality of life despite normal TSH under therapy with levothyroxine (L-T4). A new randomised, double-blind trial demonstrated better QoL under L-T4 + L-T3 compared to L-T4 alone. πŸ§ͺ🩺 #MedSky

https://pubmed.ncbi.nlm.nih.gov/39865226/

https://doi.org/10.1186/s12902-025-01840-4
Post image

Comments